CYP2C56P

Across TCGA pan-cancer cohorts, CYP2C56P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of CYP2C56P’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where CYP2C56P RNA is repressed in tumor relative to normal tissue. In most cancer types CYP2C56P is over-expressed in tumor, although a few such as STAD show the opposite, repressed pattern.

STAD are the cancer types where CYP2C56P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CYP2C56P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	II,III,IV	−0.038	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

CYP2C56P–STAD

Open the STAD breakdown →